ArticleDiscover nano2026
Comparative evaluation of biogenic hydroxyapatite derived from fish bones and synthetic hydroxyapatite for the removal of flucloxacillin sodium.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, a comparative study of the adsorption of flucloxacillin sodium (FLCX-Na) from aqueous solution onto synthetic hydroxyapatite (Syn-CaHAp) and biogenic hydroxyapatite from fish bones (B-CaHAp) is reported. The adsorbents were prepared and characterized by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), thermogravimetric/differential thermal analysis (TGA/DTA), scanning electron microscopy coupled with energy-dispersive (SEM-EDS) and Transmission electron microscopy (TEM). The characterization results revealed that B-CaHAp possesses calcium-deficient carbonate-substituted apatite structure with heterogeneous morphology and higher density of accessible adsorption sites. Batch adsorption experiments indicated that the adsorbent dosage, contact time, initial concentration, and pH of the solution had a significant effect on the adsorption performance. The maximum experimental adsorption capacities of Syn-CaHAp and B-CaHAp were 15 and 26 mg·g
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.